![Randomized Phase III Study of Gemcitabine Plus S-1, S-1 Alone, or Gemcitabine Alone in Patients With Locally Advanced and Metastatic Pancreatic Cancer in Japan and Taiwan: GEST Study]()
Randomized Phase III Study of Gemcitabine Plus S-1, S-1 Alone, or Gemcitabine Alone in Patients With Locally Advanced and Metastatic Pancreatic Cancer in Japan and Taiwan: GEST StudyUeno, H.; Ioka, T.; Ikeda, M.; Ohkawa, S.; Yanagimoto, H.; Boku, N.; Fukutomi, A.; Sugimori, K.; Baba, H.; Yamao, K.; Shimamura, T.; Sho, M.; Kitano, M.; Cheng, A.-L.; Mizumoto, K.; Chen, J.-S.; Furuse, J.; Funakoshi, A.; Hatori, T.; Yamaguchi, T.; Egawa, S.; Sato, A.; Ohashi, Y.; Okusaka, T.; Tanaka, M. · Journal of Clinical Oncology · 2013